Developing novel non-hydroxamate histone deacetylaseinhibitors: the chelidamic warhead

Developing novel non-hydroxamate histone deacetylaseinhibitors: the chelidamic warhead Design, synthesis and preliminary biological evaluation of new hydroxamate histone deacetylase inhibitors as potential antileukemic agents 2-Aroylindoles and 2-Aroylbenzofurans with N-Hydroxyacrylamide Substructures as a Novel Series of Rationally Designed Histone Deacetylase Inhibitors 1,3,4-Oxadiazole-Containing Histone Deacetylase Inhibitors: Anticancer Activities in Cancer Cells Novel histone deacetylase inhibitors: design, synthesis, enzyme inhibition, and binding mode study of SAHA-Based non-hydroxamates Antiproliferative and Differentiating Activities of a Novel Series of Histone Deacetylase Inhibitors Synthesis, Biological Evaluation, and Molecular Docking of Ugi Products Containing a Zinc-Chelating Moiety as Novel Inhibitors of Histone Deacetylases A series of novel, potent, and selective histone deacetylase inhibitors Histone deacetylase inhibitors with a primary amide zinc binding group display antitumor activity in xenograft model Design, synthesis and preliminary evaluation of a series of histone deacetylase inhibitors carrying a benzodiazepine ring